OR7A17
gene geneOn this page
Also known as HTPCRX19
Summary
OR7A17 (olfactory receptor family 7 subfamily A member 17, HGNC:8363) is a protein-coding gene on chromosome 19p13.12, encoding Olfactory receptor 7A17 (O14581). Odorant receptor. It is a selective cancer dependency (DepMap: 24.4% of cell lines).
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 26333 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 53 total
- Cancer dependency (DepMap): dependent in 24.4% of screened cell lines
- MANE Select transcript:
NM_030901
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:8363 |
| Approved symbol | OR7A17 |
| Name | olfactory receptor family 7 subfamily A member 17 |
| Location | 19p13.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HTPCRX19 |
| Ensembl gene | ENSG00000185385 |
| Ensembl biotype | protein_coding |
| Entrez | 26333 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000641113, ENST00000642123
RefSeq mRNA: 1 — MANE Select: NM_030901
NM_030901
CCDS: CCDS12319
Canonical transcript exons
ENST00000641113 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003812396 | 14881774 | 14881871 |
| ENSE00003813469 | 14878203 | 14881551 |
| ENSE00003813914 | 14885941 | 14886132 |
Expression profiles
Bgee: expression breadth tissue_specific, 1 present calls, max score 52.83.
Top tissues by expression
231 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sural nerve | UBERON:0015488 | 52.83 | silver quality |
| tendon of biceps brachii | UBERON:0008188 | 52.68 | gold quality |
| endothelial cell | CL:0000115 | 51.39 | gold quality |
| buccal mucosa cell | CL:0002336 | 51.35 | gold quality |
| colonic epithelium | UBERON:0000397 | 45.16 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| oviduct epithelium | UBERON:0004804 | 43.21 | gold quality |
| amniotic fluid | UBERON:0000173 | 43.00 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| bone marrow cell | CL:0002092 | 42.36 | gold quality |
| skin of hip | UBERON:0001554 | 41.69 | silver quality |
| vastus lateralis | UBERON:0001379 | 41.41 | gold quality |
| quadriceps femoris | UBERON:0001377 | 41.37 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 41.19 | gold quality |
| upper leg skin | UBERON:0004262 | 41.13 | silver quality |
| palpebral conjunctiva | UBERON:0001812 | 41.10 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 40.98 | gold quality |
| muscle tissue | UBERON:0002385 | 40.69 | gold quality |
| jejunal mucosa | UBERON:0000399 | 40.59 | gold quality |
| biceps brachii | UBERON:0001507 | 40.57 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 40.45 | gold quality |
| myocardium | UBERON:0002349 | 40.45 | gold quality |
| gingival epithelium | UBERON:0001949 | 40.43 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 40.33 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 40.29 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 40.27 | gold quality |
| jejunum | UBERON:0002115 | 40.18 | gold quality |
| cartilage tissue | UBERON:0002418 | 40.06 | gold quality |
| cortical plate | UBERON:0005343 | 40.00 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.04 |
Regulation
Is transcription factor: no
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 24.4% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 1)
- Olfactory Receptor OR7A17 Expression Correlates with All-Trans Retinoic Acid (ATRA)-Induced Suppression of Proliferation in Human Keratinocyte Cells. (PMID:34830183)
Cross-species orthologs
7 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or7a36 | ENSMUSG00000046493 |
| mus_musculus | Or7a40 | ENSMUSG00000048101 |
| mus_musculus | Or7a42 | ENSMUSG00000094080 |
| mus_musculus | Or7a38 | ENSMUSG00000094673 |
| rattus_norvegicus | Or7a38d | ENSRNOG00000073775 |
| rattus_norvegicus | Or7a36 | ENSRNOG00000086119 |
| rattus_norvegicus | Or7a38e | ENSRNOG00000091284 |
Paralogs (130): OR1I1 (ENSG00000094661), OR12D3 (ENSG00000112462), OR7A10 (ENSG00000127515), OR7C2 (ENSG00000127529), OR7C1 (ENSG00000127530), OR1E2 (ENSG00000127780), OR1J1 (ENSG00000136834), OR1L4 (ENSG00000136939), OR4D1 (ENSG00000141194), OR4K1 (ENSG00000155249), OR3A3 (ENSG00000159961), OR7G1 (ENSG00000161807), OR1Q1 (ENSG00000165202), OR1K1 (ENSG00000165204), OR4K2 (ENSG00000165762), OR4D6 (ENSG00000166884), OR1F1 (ENSG00000168124), OR4K14 (ENSG00000169484), OR4K15 (ENSG00000169488), OR7G3 (ENSG00000170920), OR7G2 (ENSG00000170923), OR1M1 (ENSG00000170929), OR4D5 (ENSG00000171014), OR1L6 (ENSG00000171459), OR1L3 (ENSG00000171481), OR1L8 (ENSG00000171496), OR1N2 (ENSG00000171501), OR1N1 (ENSG00000171505), OR2AT4 (ENSG00000171561), OR1A1 (ENSG00000172146), OR1A2 (ENSG00000172150), OR4C11 (ENSG00000172188), OR4X2 (ENSG00000172208), OR4D9 (ENSG00000172742), OR10K1 (ENSG00000173285), OR1L1 (ENSG00000173679), OR7D4 (ENSG00000174667), OR4S2 (ENSG00000174982), OR4B1 (ENSG00000175619), OR4D11 (ENSG00000176200)
Protein
Protein identifiers
Olfactory receptor 7A17 — O14581 (reviewed: O14581)
All UniProt accessions (2): A0A126GVR5, O14581
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_112163* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
Pfam: PF13853
UniProt features (22 total): topological domain 8, transmembrane region 7, sequence variant 4, chain 1, glycosylation site 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O14581-F1 | 85.47 | 0.50 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 97–189
Glycosylation sites (1): 5
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 37 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, chr19p13, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, IL15_UP.V1_DN, TGFB_UP.V1_DN, ZNF781_TARGET_GENES
GO Biological Process (4): signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (3): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984), protein binding (GO:0005515)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
106 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR7A17 | SCART1 | Q4G0T1 | 479 |
| OR7A17 | KIF26A | Q9ULI4 | 370 |
| OR7A17 | COL21A1 | Q96P44 | 311 |
| OR7A17 | PRR7 | Q8TB68 | 303 |
| OR7A17 | NALCN | Q8IZF0 | 293 |
| OR7A17 | TRIM52 | Q96A61 | 289 |
| OR7A17 | BTNL9 | Q6UXG8 | 285 |
| OR7A17 | LMAN2 | Q12907 | 279 |
| OR7A17 | FAF2 | Q96CS3 | 272 |
| OR7A17 | KDM3B | Q7LBC6 | 270 |
| OR7A17 | COL9A3 | Q14050 | 269 |
| OR7A17 | COL5A3 | P25940 | 251 |
| OR7A17 | TRIM41 | Q8WV44 | 247 |
| OR7A17 | B4GALT7 | Q9UBV7 | 238 |
| OR7A17 | COL7A1 | Q02388 | 226 |
IntAct
13 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CYSRT1 | OR7A17 | psi-mi:“MI:0915”(physical association) | 0.560 |
| OR7A17 | KRTAP11-1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| OR7A17 | ECE1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ECE1 | OR7A17 | psi-mi:“MI:0915”(physical association) | 0.370 |
| OR7A17 | ACTB | psi-mi:“MI:0914”(association) | 0.350 |
| OR7A17 | CYSRT1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| OR7A17 | KRTAP11-1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (5): OR7A17 (Two-hybrid), CYSRT1 (Two-hybrid), ACTC1 (Affinity Capture-MS), ACTB (Affinity Capture-MS), OR7A17 (Affinity Capture-MS)
ESM2 similar proteins: A0A2R8YED5, A6NM03, O14581, O60412, O76099, O95006, O95047, O95371, P34982, P34984, P47884, P58170, Q15619, Q15622, Q5TZ20, Q60883, Q60887, Q60891, Q6IFH4, Q7Z3T1, Q8N628, Q8NG84, Q8NG95, Q8NG98, Q8NG99, Q8NGA0, Q8NGA1, Q8NGA2, Q8NGQ5, Q8NGR9, Q8NGS1, Q8NGS2, Q8NGS3, Q8NGV0, Q8NGW1, Q8NGX1, Q8NH06, Q8NH80, Q8NHA4, Q95157
Diamond homologs: A0A2R8YED5, O14581, O43749, O76099, O95221, P0C626, P0C7N1, P0C7N5, P0DN81, P23266, P23275, P30955, P47890, P58173, P58181, P59922, Q15617, Q15619, Q15622, Q60878, Q60881, Q60895, Q6IEU7, Q6UXT6, Q7TQQ0, Q7Z3T1, Q8N0Y5, Q8N146, Q8N162, Q8N628, Q8NG98, Q8NGA1, Q8NGC2, Q8NGE5, Q8NGF4, Q8NGF8, Q8NGG0, Q8NGG3, Q8NGG4, Q8NGG8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
53 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 52 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
246 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:14880762:C:A | donor_gain | 0.7400 |
| 19:14881426:A:AC | donor_gain | 0.6800 |
| 19:14881427:C:CC | donor_gain | 0.6800 |
| 19:14881427:CT:C | donor_gain | 0.6700 |
| 19:14880656:T:TA | donor_gain | 0.6600 |
| 19:14880594:C:CT | acceptor_gain | 0.6500 |
| 19:14880592:CCCG:C | acceptor_gain | 0.6400 |
| 19:14880594:C:T | acceptor_gain | 0.6400 |
| 19:14880582:CACAC:C | acceptor_gain | 0.6300 |
| 19:14880595:G:C | acceptor_gain | 0.6200 |
| 19:14880584:CAC:C | acceptor_gain | 0.6100 |
| 19:14880593:CCG:C | acceptor_gain | 0.6100 |
| 19:14880595:G:GC | acceptor_gain | 0.6000 |
| 19:14881068:G:GA | donor_gain | 0.6000 |
| 19:14880599:A:T | acceptor_gain | 0.5900 |
| 19:14881055:T:C | donor_gain | 0.5900 |
| 19:14881180:A:C | donor_gain | 0.5900 |
| 19:14880595:G:T | acceptor_gain | 0.5800 |
| 19:14880761:T:TA | donor_gain | 0.5800 |
| 19:14880657:C:A | donor_gain | 0.5600 |
| 19:14880601:C:CT | acceptor_gain | 0.5400 |
| 19:14881055:T:TA | donor_gain | 0.5400 |
| 19:14880731:C:CT | donor_gain | 0.5300 |
| 19:14881408:A:C | donor_gain | 0.5300 |
| 19:14880484:C:CC | acceptor_gain | 0.5100 |
| 19:14880838:T:TA | donor_gain | 0.5100 |
| 19:14881031:C:T | acceptor_gain | 0.5000 |
| 19:14881405:T:C | donor_gain | 0.5000 |
| 19:14880583:ACACC:A | acceptor_loss | 0.4800 |
| 19:14880584:CACCT:C | acceptor_loss | 0.4800 |
AlphaMissense
2012 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:14881320:A:C | F12L | 0.872 |
| 19:14881320:A:T | F12L | 0.872 |
| 19:14881322:A:G | F12L | 0.872 |
| 19:14880852:G:C | F168L | 0.852 |
| 19:14880852:G:T | F168L | 0.852 |
| 19:14880854:A:G | F168L | 0.852 |
| 19:14881002:C:A | M118I | 0.851 |
| 19:14881002:C:G | M118I | 0.851 |
| 19:14881002:C:T | M118I | 0.851 |
| 19:14880825:A:C | F177L | 0.819 |
| 19:14880825:A:T | F177L | 0.819 |
| 19:14880827:A:G | F177L | 0.819 |
| 19:14880483:A:C | S291R | 0.816 |
| 19:14880483:A:T | S291R | 0.816 |
| 19:14880485:T:G | S291R | 0.816 |
| 19:14880991:C:G | R122P | 0.815 |
| 19:14880603:A:C | F251L | 0.812 |
| 19:14880603:A:T | F251L | 0.812 |
| 19:14880605:A:G | F251L | 0.812 |
| 19:14881263:A:C | F31L | 0.809 |
| 19:14881263:A:T | F31L | 0.809 |
| 19:14881265:A:G | F31L | 0.809 |
| 19:14880642:A:C | F238L | 0.797 |
| 19:14880642:A:T | F238L | 0.797 |
| 19:14880644:A:G | F238L | 0.797 |
| 19:14881230:A:C | N42K | 0.787 |
| 19:14881230:A:T | N42K | 0.787 |
| 19:14880648:C:A | K236N | 0.775 |
| 19:14880648:C:G | K236N | 0.775 |
| 19:14880993:A:C | D121E | 0.768 |
dbSNP variants (sampled 300 via entrez): RS1000035896 (19:14882288 G>T), RS1000706317 (19:14879752 C>T), RS1000736671 (19:14884207 GA>G,GAA), RS1000815249 (19:14878517 C>A), RS1001073518 (19:14884044 C>T), RS1001579944 (19:14884585 T>C), RS1001752483 (19:14879473 C>T), RS1001941557 (19:14884636 C>T), RS1002309028 (19:14884364 G>A,T), RS1002696916 (19:14887046 T>A), RS1002909036 (19:14885697 C>A), RS1003357674 (19:14878294 C>T), RS1003429671 (19:14877950 C>T), RS1004360480 (19:14878402 T>A,C), RS1004494049 (19:14887862 T>C,G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008114_16 | Type 2 diabetes | 5.000000e-06 |
| GCST008748_11 | Epigenetic age acceleration in alcohol use disorder | 9.000000e-07 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0000473 | epigenetic status |
| EFO:0022597 | aging |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | increases reaction, affects binding | 1 |
| Resveratrol | decreases expression, affects cotreatment | 1 |
| Fulvestrant | increases methylation | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Asbestos, Crocidolite | affects expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.